+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceuticals Global Market Report 2021: COVID-19 Impact and Recovery to 2030

  • ID: 5292738
  • Report
  • February 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer
  • Sanofi
Pharmaceuticals Global Market Report 2021: COVID-19 Impact and Recovery to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global pharmaceuticals market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the pharmaceuticals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Pharmaceuticals market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceuticals market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The pharmaceuticals market section of the report gives context. It compares the pharmaceuticals market with other segments of the pharmaceuticals market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, pharmaceuticals indicators comparison.
Scope

Markets Covered:
1) By Type: Pharmaceutical Drugs; Biologics
2) By Distribution Channel: Supermarkets/Hypermarkets; Convenience Stores; E-Commerce; Others
3) By Nature: Organic; Conventional

Subsegments Covered: Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Respiratory Diseases Drugs; Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines

Companies Mentioned: Pfizer; F. Hoffmann-La Roche Ltd; Sanofi; Johnson & Johnson; Merck & Co.

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, pharmaceuticals indicators comparison.

Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer
  • Sanofi
1. Executive Summary

2. Report Structure

3. Pharmaceuticals Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Pharmaceuticals Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Pharmaceuticals Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Pharmaceuticals Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Pharmaceuticals Market Trends and Strategies

8. Impact of COVID-19 on Pharmaceuticals

9. Pharmaceuticals Market Size and Growth
9.1. Market Size
9.2. Historic Market Growth, Value ($ Billion)
9.2.1. Drivers of the Market
9.2.2. Restraints on the Market
9.3. Forecast Market Growth, Value ($ Billion)
9.3.1. Drivers of the Market
9.3.2. Restraints on the Market

10. Pharmaceuticals Market Regional Analysis
10.1. Global Pharmaceuticals Market, 2020, by Region, Value ($ Billion)
10.2. Global Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region
10.3. Global Pharmaceuticals Market, Growth and Market Share Comparison, by Region

11. Pharmaceuticals Market Segmentation
11.1. Global Pharmaceuticals Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Pharmaceutical Drugs
  • Biologics
11.2. Global Pharmaceuticals Market, Segmentation by Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
11.3. Global Pharmaceuticals Market, Segmentation by Route of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Others
11.4. Global Pharmaceuticals Market, Segmentation by Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Branded Drugs
  • Generic Drugs
11.5. Global Pharmaceuticals Market, Segmentation by Mode of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
12. Pharmaceuticals Market Segments
12.1. Global Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion) - Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Respiratory Diseases Drugs
12.2. Global Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion) - Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines

13. Pharmaceuticals Market Metrics
13.1. Pharmaceuticals Market Size, Percentage of GDP, 2015-2025, Global
13.2. Per Capita Average Pharmaceuticals Market Expenditure, 2015-2025, Global

14. Asia-Pacific Pharmaceuticals Market
14.1. Asia-Pacific Pharmaceuticals Market Overview
  • Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Asia-Pacific, Pharmaceuticals Market, 2020, by Country, Value ($ Billion)
14.3. Asia-Pacific, Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
14.4. Asia-Pacific, Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
14.5. Asia-Pacific, Pharmaceuticals Market Metrics
14.5.1. Per Capita Average Pharmaceuticals Expenditure, 2015-2025, Asia-Pacific Countries
14.5.2. Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2020, Asia-Pacific Countries
14.5.3. Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2020, Asia-Pacific Countries
14.6. Asia-Pacific Pharmaceuticals Market, Segmentation by Type
14.6.1. Asia-Pacific Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.6.1. Asia-Pacific Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.6.2. Asia-Pacific Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7. Asia-Pacific Pharmaceuticals Market: Country Analysis
14.7.1. China Pharmaceuticals Market
14.7.1.1. China Pharmaceuticals Market Overview
14.7.1.2. China Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.1.3. China Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.1.4. China Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.2. Australia Pharmaceuticals Market
14.7.2.1. Australia Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.2.2. Australia Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.2.3. Australia Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.3. Hong Kong Pharmaceuticals Market
14.7.3.1. Hong Kong Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.4. India Pharmaceuticals Market
14.7.4.1. India Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.4.2. India Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.4.3. India Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.5. Indonesia Pharmaceuticals Market
14.7.5.1. Indonesia Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.5.2. Indonesia Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.5.3. Indonesia Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.6. Japan Pharmaceuticals Market
14.7.6.1. Japan Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.6.2. Japan Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.6.3. Japan Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.7. Malaysia Pharmaceuticals Market
14.7.7.1. Malaysia Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.8. New Zealand Pharmaceuticals Market
14.7.8.1. New Zealand Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.9. Philippines Pharmaceuticals Market
14.7.9.1. Philippines Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.10. Singapore Pharmaceuticals Market
14.7.10.1. Singapore Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.11. South Korea Pharmaceuticals Market
14.7.11.1. South Korea Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.4.2. South Korea Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.4.3. South Korea Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.12. Thailand Pharmaceuticals Market
14.7.12.1. Thailand Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.13. Vietnam Pharmaceuticals Market
14.7.13.1. Vietnam Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

15. Western Europe Pharmaceuticals Market
15.1. Western Europe Pharmaceuticals Market Overview
15.2. Western Europe, Pharmaceuticals Market, 2020, by Country, Value ($ Billion)
15.3. Western Europe, Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
15.4. Western Europe, Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
15.5. Western Europe, Pharmaceuticals Market Metrics
15.5.1. Per Capita Average Pharmaceuticals Expenditure, 2015-2025, Western Europe Countries
15.5.2. Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2020, Western Europe Countries
15.5.3. Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2020, Western Europe Countries
15.6. Western Europe Pharmaceuticals Market, Segmentation by Type
15.6.1. Western Europe Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.6.2. Western Europe Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.6.3. Western Europe Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7. Western Europe Pharmaceuticals Market: Country Analysis
15.7.1. Austria Pharmaceuticals Market
15.7.1.1. Austria Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.2. Belgium Pharmaceuticals Market
15.7.2.1. Belgium Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.3. Denmark Pharmaceuticals Market
15.7.3.1. Denmark Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.4. Finland Pharmaceuticals Market
15.7.4.1. Finland Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.5. France Pharmaceuticals Market
15.7.5.1. France Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.5.2. France Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.5.3. France Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.6. Germany Pharmaceuticals Market
15.7.6.1. Germany Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.6.2. Germany Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.6.3. Germany Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.7. Ireland Pharmaceuticals Market
15.7.7.1. Ireland Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.8. Italy Pharmaceuticals Market
15.7.8.1. Italy Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.9. Netherlands Pharmaceuticals Market
15.7.9.1. Netherlands Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.10. Norway Pharmaceuticals Market
15.7.10.1. Norway Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.11. Portugal Pharmaceuticals Market
15.7.11.1. Portugal Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.12. Spain Pharmaceuticals Market
15.7.12.1. Spain Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.13. Sweden Pharmaceuticals Market
15.7.13.1. Sweden Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.14. Switzerland Pharmaceuticals Market
15.7.14.1. Switzerland Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.15. UK Pharmaceuticals Market
15.7.15.1. UK Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.15.2. UK Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.15.3. UK Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

16. Eastern Europe Pharmaceuticals Market
16.1. Eastern Europe Pharmaceuticals Market Overview
16.2. Eastern Europe, Pharmaceuticals Market, 2020, by Country, Value ($ Billion)
16.3. Eastern Europe, Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
16.4. Eastern Europe, Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
16.5. Eastern Europe, Pharmaceuticals Market Metrics
16.5.1. Per Capita Average Pharmaceuticals Expenditure, 2015-2025, Eastern Europe Countries
16.5.2. Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2020, Eastern Europe Countries
16.5.3. Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2020, Eastern Europe Countries
16.6. Eastern Europe Pharmaceuticals Market, Segmentation by Type
16.6.1. Eastern Europe Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.6.2. Eastern Europe Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.6.3. Eastern Europe Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7. Eastern Europe Pharmaceuticals Market: Country Analysis
16.7.1. Czech Republic Pharmaceuticals Market,
16.7.1.1. Czech Republic Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.2. Poland Pharmaceuticals Market
16.7.2.1. Poland Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.3. Romania Pharmaceuticals Market
16.7.3.1. Romania Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.4. Russia Pharmaceuticals Market
16.7.4.1. Russia Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.4.2. Russia Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.4.3. Russia Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

17. North America Pharmaceuticals Market
17.1. North America Pharmaceuticals Market Overview
17.2. North America, Pharmaceuticals Market, 2020, by Country, Value ($ Billion)
17.3. North America, Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
17.4. North America, Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
17.5. North America, Pharmaceuticals Market Metrics
17.5.1. Per Capita Average Pharmaceuticals Expenditure, 2015-2025, North America Countries
17.5.2. Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2020, North America Countries
17.5.3. Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2020, North America Countries
17.6. North America Pharmaceuticals Market, Segmentation by Type
17.6.1. North America Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.6.2. North America Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.6.3. North America Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7. North America Pharmaceuticals Market: Country Analysis
17.7.1. Canada Pharmaceuticals Market
17.7.1.1. Canada Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.2. Mexico Pharmaceuticals Market
17.7.2.1. Mexico Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.3. USA Pharmaceuticals Market
17.7.3.1. USA Pharmaceuticals Market Overview
17.7.3.2. USA Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.3.3. USA Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.3.4. USA Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

18. South America Pharmaceuticals Market
18.1. South America Pharmaceuticals Market Overview
18.2. South America, Pharmaceuticals Market, 2020, by Country, Value ($ Billion)
18.3. South America, Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
18.4. South America, Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
18.5. South America, Pharmaceuticals Market Metrics
18.5.1. Per Capita Average Pharmaceuticals Expenditure, 2015-2025, South America Countries
18.5.2. Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2020, South America Countries
18.5.3. Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2020, South America Countries
18.6. South America Pharmaceuticals Market, Segmentation by Type
18.6.1. South America Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.6.2. South America Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.6.3. South America Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7. South America Pharmaceuticals Market: Country Analysis
18.7.1. Argentina Pharmaceuticals Market
18.7.1.1. Argentina Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.2. Brazil Pharmaceuticals Market
18.7.2.1. Brazil Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.2.2. Brazil Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.2.3. Brazil Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.3. Chile Pharmaceuticals Market
18.7.3.1. Chile Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.4. Colombia Pharmaceuticals Market
18.7.4.1. Colombia Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.5. Peru Pharmaceuticals Market
18.7.5.1. Peru Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.6. Venezuela Pharmaceuticals Market
18.7.6.1. Venezuela Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

19. Middle East Pharmaceuticals Market
19.1. Middle East Pharmaceuticals Market Overview
19.2. Middle East, Pharmaceuticals Market, 2020, by Country, Value ($ Billion)
19.3. Middle East, Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
19.4. Middle East, Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
19.5. Middle East, Pharmaceuticals Market Metrics
19.5.1. Per Capita Average Pharmaceuticals Expenditure, 2015-2025, Middle East Countries
19.5.2. Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2020, Middle East Countries
19.5.3. Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2020, Middle East Countries
19.6. Middle East Pharmaceuticals Market, Segmentation by Type
19.6.1. Middle East Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.6.2. Middle East Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.6.3. Middle East Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7. Middle East Pharmaceuticals Market: Country Analysis
19.7.1. Saudi Arabia Pharmaceuticals Market
19.7.1.1. Saudi Arabia Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.2. Israel Pharmaceuticals Market
19.7.2.1. Israel Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.3. Turkey Pharmaceuticals Market
19.7.3.1. Turkey Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.4. UAE Pharmaceuticals Market
19.7.4.1. UAE Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

20. Africa Pharmaceuticals Market
20.1. Africa Pharmaceuticals Market Overview
20.2. Africa, Pharmaceuticals Market, 2020, by Country, Value ($ Billion)
20.3. Africa, Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
20.4. Africa, Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
20.5. Africa, Pharmaceuticals Market Metrics
20.5.1. Per Capita Average Pharmaceuticals Expenditure, 2015-2025, Africa Countries
20.5.2. Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2020, Africa Countries
20.5.3. Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2020, Africa Countries
20.6. Africa Pharmaceuticals Market, Segmentation by Type
20.6.1. Africa Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
20.6.2. Africa Pharmaceutical Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
20.6.3. Africa Biologics Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
20.7. Africa Pharmaceuticals Market: Country Analysis
20.7.1. Egypt Pharmaceuticals Market
20.7.1.1. Egypt Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
20.7.2. Nigeria Pharmaceuticals Market
20.7.2.1. Nigeria Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
20.7.3. South Africa Pharmaceuticals Market
20.7.3.1. South Africa Pharmaceuticals Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

21. Pharmaceuticals Market Competitive Landscape
21.1. Competitive Market Overview
21.2. Market Shares
21.3. Company Profiles
21.3.1. Pfizer
21.3.1.1. Company Overview
21.3.1.2. Products and Services
21.3.1.3. Strategy
21.3.1.4. Financial Performance
21.3.2. F. Hoffmann-La Roche Ltd
21.3.2.1. Company Overview
21.3.2.2. Products and Services
21.3.2.3. Strategy
21.3.2.4. Financial Performance
21.3.3. Sanofi
21.3.3.1. Company Overview
21.3.3.2. Products and Services
21.3.3.3. Strategy
21.3.3.4. Financial Performance
21.3.4. Johnson & Johnson
21.3.4.1. Company Overview
21.3.4.2. Products and Services
21.3.4.3. Strategy
21.3.4.4. Financial Performance
21.3.5. Merck & Co.
21.3.5.1. Company Overview
21.3.5.2. Products and Services
21.3.5.3. Strategy
21.3.5.4. Financial Performance

22. Key Mergers and Acquisitions in the Pharmaceuticals Market

23. Recommendations
23.1. Global Pharmaceuticals Market in 2025 - Growth Countries
23.2. Global Pharmaceuticals Market in 2025 - Growth Segments
23.3. Global Pharmaceuticals Market in 2025 - Growth Strategies

24. Appendix
24.1. NAICS Definitions of Industry Covered in This Report
24.2. Abbreviations
24.3. Currencies
24.4. Research Inquiries
24.5. About the Publisher

25. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer
  • Sanofi
Major companies in the pharmaceuticals market include Pfizer; F. Hoffmann-La Roche Ltd; Sanofi; Johnson & Johnson and Merck & Co.

The global pharmaceuticals market is expected to grow from $1228.45 billion in 2020 to $1250.24 billion in 2021 at a compound annual growth rate (CAGR) of 1.8%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $1700.97 billion in 2025 at a CAGR of 8%.

The pharmaceuticals market consists of sales of pharmaceuticals and related services by entities (organizations, sole traders and partnerships) that produce pharmaceuticals used in treating diseases. Pharmaceuticals can be any type of drugs that are used for medicinal purposes, in the treatment of diseases. This industry includes establishments that produce biologics and pharmaceutical drugs. The pharmaceuticals market is segmented into pharmaceutical drugs; and biologics.

North America was the largest region in the global pharmaceuticals market, accounting for 46% of the market in 2020. Asia Pacific was the second largest region accounting for 26% of the global pharmaceuticals market. Africa was the smallest region in the global pharmaceuticals market.

Pharmaceutical companies are offering drugs for customized individual treatment for various diseases. Personalized medicine, also referred to as precision medicine, aims to provide medical care according to the patient’s individual characteristics and genetic makeup. Precision therapies are increasingly being adopted as firms increasingly let go of the one-size-fits-all model for common medical conditions. Major companies such as GSK, Teva Pharmaceuticals and AstraZeneca are investing in development of personalized medicines.

The biologics market growth was limited due to severe shortage of skilled workforce for developing biologics drugs which require specialized skillsets. These skillsets are limited to some research organizations and medical equipment companies in the USA and Europe. As of 2018, 40% of the biopharma industry was facing difficulties in hiring for process development staff due to shortage of talent. This shortage led to rise in competition and salaries for the limited talent pool available for biologics manufacturing, thereby limiting growth of the market during the historic period.

The population profile of most countries is becoming older. According to the Population Reference Bureau, the share of population over the age of 65 in the global population increased from 8% in 2015 to 9% in 2019. The global population aged 65 years or over was 703 million in 2019. This rise in the aging population increased the patient pool of many chronic diseases such as rheumatoid arthritis, hypertension, diabetes and cancer. The increase in the patient pool drove the demand for pharmaceuticals used in the treatment of these diseases, significantly impacting market growth during this period.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Pfizer
  • F. Hoffmann-La Roche Ltd
  • Sanofi
  • Johnson & Johnson
  • Merck & Co.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll